RC

Rahul Chandulal Limbachiya

Active Director Director DIN 06820011
DIN 06820011 First appointment Mar 2014 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Total affiliations 5 Since Mar 2014
Shareholding value •••• Premium profile

About Rahul Chandulal Limbachiya

Data last updated:

Rahul Chandulal Limbachiya is a Director at Manisha Analytical Laboratories Private Limited (since 2014), Director at Bee Pharmo Labs Private Limited (since 2014) and Director at Hindustan Biosynth Limited (since 2014), and holds 2 more current directorships. The companies operate in Healthcare, Food and Beverages and Pharma. The 5 current companies with reported revenue have a combined latest revenue of ₹82.21 Cr; the largest is Manisha Analytical Laboratories Private Limited at ₹48.79 Cr (FY 2025).

DIN 06820011
Primary Designation Director
Industry Healthcare
First Appointment 13 Mar 2014
Oldest Company Age 38 yrs
Largest company Manisha Analytical Laboratories Private Limited · ₹48.79 Cr (FY 2025)
Combined revenue ₹82.21 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Aug 20141988₹48.79 Cr (FY 2025)Active
Bee Pharmo Labs Private Limited U73100MH1988PTC047818
Director19 Aug 20141988₹26.05 Cr (FY 2025)Active
Hindustan Biosynth Limited U24231GJ2004PLC043432
Director13 Mar 20142004₹6.98 Cr (FY 2025)Active
Hindustan Pharmachem Limited U24232GJ2003PLC042721
Director13 Mar 20142003₹27 Lakh (FY 2022)Active
Director13 Mar 20141994₹12.3 Lakh (FY 2022)Active

Directorship timeline

Open interactive timeline →
Health And Hygiene Products(India)Limited
Manisha Analytical Laboratories Private Limited
Hindustan Biosynth Limited
Hindustan Pharmachem Limited
Premium access

Shareholding and investment profile for Rahul Chandulal Limbachiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rahul Chandulal Limbachiya

Rahul Chandulal Limbachiya currently holds 5 directorships: Manisha Analytical Laboratories Private Limited (Director, since 19 Aug 2014, revenue ₹48.79 Cr (FY 2025)); Bee Pharmo Labs Private Limited (Director, since 19 Aug 2014, revenue ₹26.05 Cr (FY 2025)); Hindustan Biosynth Limited (Director, since 13 Mar 2014, revenue ₹6.98 Cr (FY 2025)); Hindustan Pharmachem Limited (Director, since 13 Mar 2014, revenue ₹27 Lakh (FY 2022)); Health And Hygiene Products(India)Limited (Director, since 13 Mar 2014, revenue ₹12.3 Lakh (FY 2022)).

Rahul Chandulal Limbachiya was first appointed on 13 Mar 2014 as Director at Hindustan Biosynth Limited.

The 5 current companies of Rahul Chandulal Limbachiya that report revenue have a combined latest revenue of ₹82.21 Cr: Manisha Analytical Laboratories Private Limited ₹48.79 Cr (FY 2025); Bee Pharmo Labs Private Limited ₹26.05 Cr (FY 2025); Hindustan Biosynth Limited ₹6.98 Cr (FY 2025); Hindustan Pharmachem Limited ₹27 Lakh (FY 2022); Health And Hygiene Products(India)Limited ₹12.3 Lakh (FY 2022).

The current boards of Rahul Chandulal Limbachiya's companies include Bhavesh Chandulal Limbachiya (Manisha Analytical Laboratories Private Limited), Chandulal Hiralal Nai (Manisha Analytical Laboratories Private Limited), Vinod Nayi Hiralal (Manisha Analytical Laboratories Private Limited), Swati Hiriyanna Shetty (Bee Pharmo Labs Private Limited), Sauhil Sudesh Bhattia (Hindustan Biosynth Limited), Sudeshkumar Banarasidas Bhatia (Hindustan Biosynth Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available